Skip to main contentAll experts

Mauricio De Aguiar Martins

ASO PROF

SR-RESEARCH DEPARTMENTS

Orcid identifier0000-0001-8336-216X (opens in a new tab)⁠
  • ASO PROF
    SR-RESEARCH DEPARTMENTS

GRANTS

  • GRANT
    "Elucidating the Impact of Local Inflammation on the Outcome of Intramuscular Gene Therapy with AAV/bNAb Vectors
    Campbell Foundation27 Aug 2026 - 14 Sep 2027
    Active
  • GRANT
    Mitigating anti-drug antibodies
    Bill & Melinda Gates Foundation27 Oct 2025 - 31 May 2027
    Active
  • GRANT
    Leveraging prenatal tolerance to improve AAV/bNAb therapy outcomes in infancy
    National Institute of Health Niaid30 Jul 2025 - 30 Jun 2030
    Active
  • GRANT
    Non-viral gene therapy with eCD4-Ig (opens in a new tab)⁠
    National Institute of Allergy and Infectious Diseases17 Jun 2025 - 31 May 2026
    People funded by this grant:
    • QUINLAN BD,
    • ALPERT MD,
    • MARTINS MA
    MORELEARN MORE (opens in a new tab)
  • GRANT
    Vectored HIV Immunotherapy via in vivo B cell editing
    National Institute of Health Niaid4 Apr 2024 - 31 Dec 2028
    Active
  • GRANT
    LNP Delivery of DNA-Encoded eCD4-Ig
    Bill & Melinda Gates Foundation18 Dec 2023 - 31 Dec 2024
    Expired
  • GRANT
    An AAV-mediated functional cure and its impact on the reservoir
    National Institute of Health Niaid21 Aug 2023 - 31 Mar 2026
    Expired
  • GRANT
    Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory
    National Institute of Health Niaid20 Mar 2023 - 30 Apr 2026
    Expired
  • GRANT
    Costimulation Blockade for Preventing Anti-Drug Antibody Responses Following AAV-Mediated Gene Therapy with Anti-HIV bnAb
    Florida Department of Health6 Dec 2022 - 30 Jun 2023
    Expired
  • GRANT
    Overcoming pre-existing immunity to AAV to enhance AAV-based HIV immunotherapies
    National Institute of Health Niaid5 Dec 2022 - 30 Nov 2027
    Active
  • GRANT
    A nonhuman primate model to study the immunological effects of feminizing hormone therapy in transgender women
    National Institute of Health Niaid2 Apr 2022 - 30 Nov 2022
    Expired
  • GRANT
    AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
    National Institute of Health Nichd2 Apr 2022 - 31 May 2026
    Expired
  • GRANT
    eCD4-Ig for preventing and treating obstetric HIV infection
    National Institute of Health Nichd2 Apr 2022 - 31 May 2026
    Expired
  • GRANT
    Ipilimumab as an adjuvant for HIV vaccines (opens in a new tab)⁠
    Office of the Director5 Aug 2016 - 30 Apr 2020
    People funded by this grant:
    • MARTINS MA
    MORELEARN MORE (opens in a new tab)